140 related articles for article (PubMed ID: 33430695)
1. Cerebrospinal Fluid Sulfonylurea Receptor-1 is Associated with Intracranial Pressure and Outcome after Pediatric TBI: An Exploratory Analysis of the Cool Kids Trial.
Zusman BE; Kochanek PM; Bell MJ; Adelson PD; Wisniewski SR; Au AK; Clark RSB; Bayır H; Janesko-Feldman K; Jha RM
J Neurotrauma; 2021 Jun; 38(12):1615-1619. PubMed ID: 33430695
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea Receptor-1: A Novel Biomarker for Cerebral Edema in Severe Traumatic Brain Injury.
Jha RM; Puccio AM; Chou SH; Chang CH; Wallisch JS; Molyneaux BJ; Zusman BE; Shutter LA; Poloyac SM; Janesko-Feldman KL; Okonkwo DO; Kochanek PM
Crit Care Med; 2017 Mar; 45(3):e255-e264. PubMed ID: 27845954
[TBL] [Abstract][Full Text] [Related]
3. Downstream
Jha RM; Desai SM; Zusman BE; Koleck TA; Puccio AM; Okonkwo DO; Park SY; Shutter LA; Kochanek PM; Conley YP
J Neurotrauma; 2019 Jun; 36(11):1804-1817. PubMed ID: 30484364
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Diversion of Cerebrospinal Fluid for Children With Severe Traumatic Brain Injury.
Bell MJ; Rosario BL; Kochanek PM; Adelson PD; Morris KP; Au AK; Schober M; Butt W; Edwards RJ; Zimmerman J; Pineda J; Le TM; Dean N; Whalen MJ; Figaji A; Luther J; Beers SR; Gupta DK; Carpenter J; Buttram S; Wisniewski SR;
JAMA Netw Open; 2022 Jul; 5(7):e2220969. PubMed ID: 35802371
[TBL] [Abstract][Full Text] [Related]
5. Serum sulfonylurea receptor-1 as a biomarker of clinical severity and prognosis in patients with traumatic brain injury.
Ying X; Chen M; Zhang J; Sun CF; Zhou J
Clin Chim Acta; 2022 Mar; 528():65-73. PubMed ID: 35092725
[TBL] [Abstract][Full Text] [Related]
6. Applying cerebral hypothermia and brain oxygen monitoring in treating severe traumatic brain injury.
Lee HC; Chuang HC; Cho DY; Cheng KF; Lin PH; Chen CC
World Neurosurg; 2010 Dec; 74(6):654-60. PubMed ID: 21492636
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia.
Su E; Bell MJ; Wisniewski SR; Adelson PD; Janesko-Feldman KL; Salonia R; Clark RS; Kochanek PM; Kagan VE; Bayır H
Dev Neurosci; 2010; 32(5-6):385-95. PubMed ID: 21124000
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 is increased in cerebrospinal fluid and associated with unfavorable outcomes in children after severe traumatic brain injury.
Salonia R; Empey PE; Poloyac SM; Wisniewski SR; Klamerus M; Ozawa H; Wagner AK; Ruppel R; Bell MJ; Feldman K; Adelson PD; Clark RS; Kochanek PM
J Neurotrauma; 2010 Oct; 27(10):1819-25. PubMed ID: 20684675
[TBL] [Abstract][Full Text] [Related]
9. Sulfonylurea Receptor 1, Transient Receptor Potential Cation Channel Subfamily M Member 4, and KIR6.2:Role in Hemorrhagic Progression of Contusion.
Gerzanich V; Stokum JA; Ivanova S; Woo SK; Tsymbalyuk O; Sharma A; Akkentli F; Imran Z; Aarabi B; Sahuquillo J; Simard JM
J Neurotrauma; 2019 Apr; 36(7):1060-1079. PubMed ID: 30160201
[TBL] [Abstract][Full Text] [Related]
10. Genetic Variants Associated With Intraparenchymal Hemorrhage Progression After Traumatic Brain Injury.
Jha RM; Zusman BE; Puccio AM; Okonkwo DO; Pease M; Desai SM; Leach M; Conley YP; Kochanek PM
JAMA Netw Open; 2021 Jul; 4(7):e2116839. PubMed ID: 34309670
[TBL] [Abstract][Full Text] [Related]
11. Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence.
Jha RM; Bell J; Citerio G; Hemphill JC; Kimberly WT; Narayan RK; Sahuquillo J; Sheth KN; Simard JM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936452
[TBL] [Abstract][Full Text] [Related]
12. Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia.
Buttram SD; Wisniewski SR; Jackson EK; Adelson PD; Feldman K; Bayir H; Berger RP; Clark RS; Kochanek PM
J Neurotrauma; 2007 Nov; 24(11):1707-17. PubMed ID: 18001201
[TBL] [Abstract][Full Text] [Related]
13. Glibenclamide for Brain Contusions: Contextualizing a Promising Clinical Trial Design that Leverages an Imaging-Based TBI Endotype.
Jha RM; Simard JM
Neurotherapeutics; 2023 Oct; 20(6):1472-1481. PubMed ID: 37306928
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.
Shore PM; Berger RP; Varma S; Janesko KL; Wisniewski SR; Clark RS; Adelson PD; Thomas NJ; Lai YC; Bayir H; Kochanek PM
J Neurotrauma; 2007 Jan; 24(1):75-86. PubMed ID: 17263671
[TBL] [Abstract][Full Text] [Related]
15. Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome.
Pérez-Bárcena J; Crespí C; Frontera G; Llompart-Pou JA; Salazar O; Goliney V; Ibáñez J; Bullock MR; de Rivero Vaccari JP
J Neurosurg; 2020 May; 134(5):1644-1649. PubMed ID: 32357337
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin in blood and cerebrospinal fluid after acute cerebral lesions: correlations with cerebral edema and intracranial pressure.
Kunz M; Nussberger J; Holtmannspötter M; Bitterling H; Plesnila N; Zausinger S
J Neurotrauma; 2013 Oct; 30(19):1638-44. PubMed ID: 23638655
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT.
Andrews PJ; Sinclair HL; Rodríguez A; Harris B; Rhodes J; Watson H; Murray G
Health Technol Assess; 2018 Aug; 22(45):1-134. PubMed ID: 30168413
[TBL] [Abstract][Full Text] [Related]
18. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome.
Zemlan FP; Jauch EC; Mulchahey JJ; Gabbita SP; Rosenberg WS; Speciale SG; Zuccarello M
Brain Res; 2002 Aug; 947(1):131-9. PubMed ID: 12144861
[TBL] [Abstract][Full Text] [Related]
19. Temporal Profiles of P-Tau, T-Tau, and P-Tau:Tau Ratios in Cerebrospinal Fluid and Blood from Moderate-Severe Traumatic Brain Injury Patients and Relationship to 6-12 Month Global Outcomes.
Rubenstein R; McQuillan L; Wang KKW; Robertson C; Chang B; Yang Z; Xu H; Williamson J; Wagner AK
J Neurotrauma; 2024 Feb; 41(3-4):369-392. PubMed ID: 37725589
[TBL] [Abstract][Full Text] [Related]
20. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
